Published: December 23rd 2024 | Updated: January 23rd 2025
Bone Predominant mCRPC Patient Case
Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: February 14th 2025 | Updated: February 19th 2025
Real-world outcomes with nadofaragene point to safety, efficacy of NMIBC treatment
Published: February 12th 2025 | Updated: February 19th 2025
UGN-101 associated with favorable long-term durability in low-grade UTUC
Published: February 15th 2025 | Updated: February 19th 2025
Gopa Iyer, MD, on durable efficacy of EV/pembrolizumab in urothelial carcinoma
Published: February 15th 2025 | Updated: February 19th 2025
EV/pembrolizumab continues to show OS, PFS benefit vs chemotherapy in la/mUC